Rendering

Component: (Network and Table)
Network
2411404 - Disclosure - Stock-Based Compensation - Schedule of Stock Option Valuation Assumptions (Details)
(http://www.acceleronpharma.com/role/StockBasedCompensationScheduleOfStockOptionValuationAssumptionsDetails)
TableSchedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis]0001280600 (http://www.sec.gov/CIK)
Share-based Compensation Arrangement by Share-based Payment AwardPeriod [Axis]
2016-01-01 - 2016-12-31
2015-01-01 - 2015-12-31
2014-01-01 - 2014-12-31
Award Type [Axis]Award Type [Axis]Award Type [Axis]
Equity OptionEquity Award [Domain]Equity OptionEquity Option
Expected volatility
65.10%  
 
67.00%  
70.90%  
Expected term (in years)
P6Y  
 
P6Y  
P6Y  
Risk-free interest rate
1.69%  
 
1.67%  
1.82%  
Expected dividend yield
0.00%  
0.00%  
0.00%  
0.00%